A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells

Small-cell lung cancer (SCLC), representing 15–20% of all lung cancers, is an aggressive malignancy with a distinct natural history, poor prognosis, and limited treatment options. We have previously identified Schwann cells (SCs), the main glial cells of the peripheral nervous system, in tumor tissu...

Full description

Bibliographic Details
Main Authors: Shuhui Cao, Yue Wang, Yan Zhou, Yao Zhang, Xuxinyi Ling, Lincheng Zhang, Jingwen Li, Yu Yang, Weimin Wang, Michael R. Shurin, Hua Zhong
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/24/6132
_version_ 1797461091581689856
author Shuhui Cao
Yue Wang
Yan Zhou
Yao Zhang
Xuxinyi Ling
Lincheng Zhang
Jingwen Li
Yu Yang
Weimin Wang
Michael R. Shurin
Hua Zhong
author_facet Shuhui Cao
Yue Wang
Yan Zhou
Yao Zhang
Xuxinyi Ling
Lincheng Zhang
Jingwen Li
Yu Yang
Weimin Wang
Michael R. Shurin
Hua Zhong
author_sort Shuhui Cao
collection DOAJ
description Small-cell lung cancer (SCLC), representing 15–20% of all lung cancers, is an aggressive malignancy with a distinct natural history, poor prognosis, and limited treatment options. We have previously identified Schwann cells (SCs), the main glial cells of the peripheral nervous system, in tumor tissues and demonstrated that they may support tumor spreading and metastasis formation in the in vitro and in vivo models. However, the role of SCs in the progression of SCLC has not been investigated. To clarify this issue, the cell proliferation assay, the annexin V apoptosis assay, and the transwell migration and invasion assay were conducted to elucidate the roles in SCLC of tumor-associated SCs (TA-SCs) in the proliferation, apoptosis, migration, and invasion of SCLC cells in vitro, compared to control group. In addition, the animal models to assess SC action’s effects on SCLC in vivo were also developed. The result confirmed that TA-SCs have a well-established and significant role in facilitating SCLC cell cancer migration and invasion of SCLC in vitro, and we also observed that SC promotes tumor growth of SCLC in vivo and that TA-SCs exhibited an advantage and show a repair-like phenotype, which allowed defining them as tumor-associated repair SCs (TAR-SCs). Potential molecular mechanisms of pro-tumorigenic activity of TAR-SCs were investigated by the screening of differentially expressed genes and constructing networks of messenger-, micro-, and long- non-coding RNA (mRNA-miRNA-lncRNA) using DMS114 cells, a human SCLC, stimulated with media from DMS114-activated SCs, non-stimulated SCs, and appropriate controls. This study improves our understanding of how SCs, especially tumor-activated SCs, may promote SCLC progression. Our results highlight a new functional phenotype of SCs in cancer and bring new insights into the characterization of the nervous system-tumor crosstalk.
first_indexed 2024-03-09T17:14:29Z
format Article
id doaj.art-89e18e5d245945bcba00006a329a7bb7
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T17:14:29Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-89e18e5d245945bcba00006a329a7bb72023-11-24T13:46:43ZengMDPI AGCancers2072-66942022-12-011424613210.3390/cancers14246132A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann CellsShuhui Cao0Yue Wang1Yan Zhou2Yao Zhang3Xuxinyi Ling4Lincheng Zhang5Jingwen Li6Yu Yang7Weimin Wang8Michael R. Shurin9Hua Zhong10Department of Pulmonary, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, ChinaDepartment of Pulmonary, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, ChinaDepartment of Pulmonary, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, ChinaDepartment of Pulmonary, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, ChinaDepartment of Pulmonary, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, ChinaDepartment of Pulmonary, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, ChinaDepartment of Pulmonary, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, ChinaDepartment of Pulmonary, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, ChinaDepartment of Pulmonary, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, ChinaDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USADepartment of Pulmonary, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, ChinaSmall-cell lung cancer (SCLC), representing 15–20% of all lung cancers, is an aggressive malignancy with a distinct natural history, poor prognosis, and limited treatment options. We have previously identified Schwann cells (SCs), the main glial cells of the peripheral nervous system, in tumor tissues and demonstrated that they may support tumor spreading and metastasis formation in the in vitro and in vivo models. However, the role of SCs in the progression of SCLC has not been investigated. To clarify this issue, the cell proliferation assay, the annexin V apoptosis assay, and the transwell migration and invasion assay were conducted to elucidate the roles in SCLC of tumor-associated SCs (TA-SCs) in the proliferation, apoptosis, migration, and invasion of SCLC cells in vitro, compared to control group. In addition, the animal models to assess SC action’s effects on SCLC in vivo were also developed. The result confirmed that TA-SCs have a well-established and significant role in facilitating SCLC cell cancer migration and invasion of SCLC in vitro, and we also observed that SC promotes tumor growth of SCLC in vivo and that TA-SCs exhibited an advantage and show a repair-like phenotype, which allowed defining them as tumor-associated repair SCs (TAR-SCs). Potential molecular mechanisms of pro-tumorigenic activity of TAR-SCs were investigated by the screening of differentially expressed genes and constructing networks of messenger-, micro-, and long- non-coding RNA (mRNA-miRNA-lncRNA) using DMS114 cells, a human SCLC, stimulated with media from DMS114-activated SCs, non-stimulated SCs, and appropriate controls. This study improves our understanding of how SCs, especially tumor-activated SCs, may promote SCLC progression. Our results highlight a new functional phenotype of SCs in cancer and bring new insights into the characterization of the nervous system-tumor crosstalk.https://www.mdpi.com/2072-6694/14/24/6132small-cell lung cancerSchwann cellstumor progressionmiRNAgene expression
spellingShingle Shuhui Cao
Yue Wang
Yan Zhou
Yao Zhang
Xuxinyi Ling
Lincheng Zhang
Jingwen Li
Yu Yang
Weimin Wang
Michael R. Shurin
Hua Zhong
A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells
Cancers
small-cell lung cancer
Schwann cells
tumor progression
miRNA
gene expression
title A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells
title_full A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells
title_fullStr A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells
title_full_unstemmed A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells
title_short A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells
title_sort novel therapeutic target for small cell lung cancer tumor associated repair like schwann cells
topic small-cell lung cancer
Schwann cells
tumor progression
miRNA
gene expression
url https://www.mdpi.com/2072-6694/14/24/6132
work_keys_str_mv AT shuhuicao anoveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT yuewang anoveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT yanzhou anoveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT yaozhang anoveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT xuxinyiling anoveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT linchengzhang anoveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT jingwenli anoveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT yuyang anoveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT weiminwang anoveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT michaelrshurin anoveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT huazhong anoveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT shuhuicao noveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT yuewang noveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT yanzhou noveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT yaozhang noveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT xuxinyiling noveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT linchengzhang noveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT jingwenli noveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT yuyang noveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT weiminwang noveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT michaelrshurin noveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells
AT huazhong noveltherapeutictargetforsmallcelllungcancertumorassociatedrepairlikeschwanncells